Stock Events

Stock Events

NovoCure 

$15.43
151
+$0.38+2.52% Friday 20:00
-$0.03-0.19%Friday 21:59After hours

Statistics

Day High
15.48
Day Low
15.43
52W High
18.92
52W Low
9.82
Volume
93,657
Avg. Volume
-
Mkt Cap
1.74B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

23JulExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.62
-0.51
-0.39
-0.28
Expected EPS
-0.332743
Actual EPS
N/A

Financials

-20.79%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.31BRevenue
-272.45MNet Income

Analyst Ratings

25.25Average Price Target
The highest estimate is 46.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVCR. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap17.02B
Zimmer Biomet Holdings, Inc. provides medical devices in orthopedics, a different approach but still in the competitive landscape of comprehensive cancer care solutions.
Intuitive Surgical
ISRG
Mkt Cap144.07B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, indirectly competing with NovoCure by providing alternative cancer treatment methods.
Medtronic
MDT
Mkt Cap101.56B
Medtronic plc offers medical technologies, services, and solutions, including cancer treatments, competing in the broader oncology market.
Boston Scientific
BSX
Mkt Cap67.32B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including oncology.
Stryker
SYK
Mkt Cap118B
Stryker Corporation specializes in medical technologies, including surgical equipment and neurotechnology products that can be used in cancer treatments.
Abbvie
ABBV
Mkt Cap382.49B
AbbVie Inc. is a research-based biopharmaceutical company with a strong portfolio in oncology, directly competing in the cancer treatment market.
Merck
MRK
Mkt Cap281.24B
Merck & Co., Inc. is known for its pharmaceutical products for treating cancer, making it a competitor in the oncology sector.
Pfizer
PFE
Mkt Cap143.68B
Pfizer Inc. is a global biopharmaceutical company with a broad range of oncology treatments, competing in the cancer care market.
Johnson & Johnson
JNJ
Mkt Cap549.78B
Johnson & Johnson engages in the research and development, manufacture, and sale of a broad range of products in the health care field, including cancer treatments.

About

NovoCure Limited operates as an oncology enterprise specializing in the development, manufacturing, and global commercialization of its proprietary Tumor Treating Fields (TTFields) technology. These innovative devices are engineered to treat solid tumor cancers, with the company's market presence spanning the United States, Europe, the Middle East, Africa, Japan, and Greater China. The company's commercialized offerings include Optune, which is indicated for glioblastoma, and Optune Lua, approved for use in malignant pleural mesothelioma. Beyond these established treatments, NovoCure actively conducts, or has completed, clinical research into the potential applications of TTFields for a broader spectrum of cancers. These investigational areas encompass brain metastases, gastric cancer, further studies in glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. Founded in 2000, NovoCure Limited is headquartered in Saint Helier, Jersey.
Show more...
CEO
Mr. William F. Doyle
Employees
1488
Country
United Kingdom
ISIN
JE00BYSS4X48

Listings

F
DE
038.F
MX
MX
NVCRN.MX
MU
DE
038.MU
STU
DE
038.STU

0 Comments

Share your thoughts

FAQ

What is NovoCure stock price today?▼
The current price of NVCR is $15.43 USD — it has increased by +2.52% in the past 24 hours. Watch NovoCure stock price performance more closely on the chart.
What is NovoCure stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange NovoCure stocks are traded under the ticker NVCR.
Is NovoCure stock price growing?▼
NVCR stock has risen by +8.05% compared to the previous week, the month change is a -10.55% fall, over the last year NovoCure has showed a -14.28% decrease.
What is NovoCure market cap?▼
Today NovoCure has the market capitalization of 1.74B
When is the next NovoCure earnings date?▼
NovoCure is going to release the next earnings report on July 23, 2026.
What were NovoCure earnings last quarter?▼
NVCR earnings for the last quarter are -0.62 USD per share, whereas the estimation was -0.51 USD resulting in a -21.05% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is NovoCure revenue for the last year?▼
NovoCure revenue for the last year amounts to 1.31B USD.
What is NovoCure net income for the last year?▼
NVCR net income for the last year is -272.45M USD.
How many employees does NovoCure have?▼
As of June 28, 2026, the company has 1,488 employees.
In which sector is NovoCure located?▼
NovoCure operates in the Health & Wellness sector.
When did NovoCure complete a stock split?▼
NovoCure has not had any recent stock splits.
Where is NovoCure headquartered?▼
NovoCure is headquartered in Baar, United Kingdom.